Disulfiram: a novel repurposed drug for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disulfiram: a novel repurposed drug for cancer therapy

Published:2021-01-10 Issue:2 Volume:87 Page:159-172
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Lu Chen,Li Xinyan,Ren Yongya,Zhang Xiao^ORCID

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-020-04216-8.pdf

Reference62 articles.

1. Johansson B (1992) A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta Psychiatr Scand 369:15–26. https://doi.org/10.1111/j.1600-0447.1992.tb03310.x

2. Wang Y, Li W, Patel SS, Cong J, Zhang N, Sabbatino F, Liu X, Qi Y, Huang P, Lee H, Taghian A, Li JJ, DeLeo AB, Ferrone S, Epperly MW, Ferrone CR, Ly A, Brachtel EF, Wang X (2014) Blocking the formation of radiation-induced breast cancer stem cells. Oncotarget 5(11):3743–3755

3. Rae C, Tesson M, Babich JW, Boyd M, Sorensen A, Mairs RJ (2013) The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells. J Nucl Med 54(6):953–960. https://doi.org/10.2967/jnumed.112.113324

4. Skrott Z, Mistrik M, Andersen KK, Friis S, Majera D, Gursky J, Ozdian T, Bartkova J, Turi Z, Moudry P, Kraus M, Michalova M, Vaclavkova J, Dzubak P, Vrobel I, Pouckova P, Sedlacek J, Miklovicova A, Kutt A, Li J, Mattova J, Driessen C, Dou QP, Olsen J, Hajduch M, Cvek B, Deshaies RJ, Bartek J (2017) Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature 552(7684):194–199. https://doi.org/10.1038/nature25016

5. Wu X, Xue X, Wang L, Wang W, Han J, Sun X, Zhang H, Liu Y, Che X, Yang J, Wu C (2018) Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer. Eur J Pharmacol 827:1–12. https://doi.org/10.1016/j.ejphar.2018.02.039

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PANoptosis signaling enables broad immune response in psoriasis: From pathogenesis to new therapeutic strategies;Computational and Structural Biotechnology Journal;2024-12

2. Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis;Frontiers in Pharmacology;2024-09-13

3. Probing the limits of tetraalkylthiuram disulfide synthesis by direct reaction of secondary amines with CS ₂ : The structures of Cy ₂ NC(S)SSC(S)NCy ₂ and Cy ₂ NC(S)SSSSC(S)NCy ₂;Phosphorus, Sulfur, and Silicon and the Related Elements;2024-09-12

4. Secondary parkinsonism associated with focal brain lesions;Frontiers in Neurology;2024-09-04

5. Triptolide-induced cuproptosis is a novel antitumor strategy for the treatment of cervical cancer;Cellular & Molecular Biology Letters;2024-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3